155 related articles for article (PubMed ID: 31249661)
1. Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells.
Tan J; Wang Y; Wang S; Wu S; Yuan Z; Zhu X
Cell Biosci; 2019; 9():48. PubMed ID: 31249661
[TBL] [Abstract][Full Text] [Related]
2. Untargeted metabolomics analysis of adipogenic transformation in OP9-DL1 cells using liquid chromatography-mass spectrometry: Implications for thymic adipogenesis.
Tan J; Wang Y; Wang S; Zhang N; Wu S; Yuan Z; Zhu X
Cell Biol Int; 2017 Apr; 41(4):447-456. PubMed ID: 28185342
[TBL] [Abstract][Full Text] [Related]
3. Notch1 Inhibits Rosiglitazone-Induced Adipogenic Differentiation in Primary Thymic Stromal Cells.
Wang Y; Tan J; Du H; Liu X; Wang S; Wu S; Yuan Z; Zhu X
Front Pharmacol; 2018; 9():1284. PubMed ID: 30483127
[TBL] [Abstract][Full Text] [Related]
4. Induction of epithelial to mesenchymal transition (EMT) and inhibition on adipogenesis: Two different sides of the same coin? Feasible roles and mechanisms of transforming growth factor β1 (TGF-β1) in age-related thymic involution.
Tan J; Wang Y; Zhang N; Zhu X
Cell Biol Int; 2016 Aug; 40(8):842-6. PubMed ID: 27189906
[TBL] [Abstract][Full Text] [Related]
5. Thiazolidinedione treatment and constitutive-PPARgamma activation induces ectopic adipogenesis and promotes age-related thymic involution.
Youm YH; Yang H; Amin R; Smith SR; Leff T; Dixit VD
Aging Cell; 2010 Aug; 9(4):478-89. PubMed ID: 20374200
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution.
Yang H; Youm YH; Dixit VD
J Immunol; 2009 Sep; 183(5):3040-52. PubMed ID: 19648267
[TBL] [Abstract][Full Text] [Related]
7. The role of prolyl hydroxylase domain protein (PHD) during rosiglitazone-induced adipocyte differentiation.
Kim J; Kwak HJ; Cha JY; Jeong YS; Rhee SD; Cheon HG
J Biol Chem; 2014 Jan; 289(5):2755-64. PubMed ID: 24338020
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells.
Liu Y; Dai B; Xu C; Fu L; Hua Z; Mei C
PLoS One; 2011; 6(12):e28915. PubMed ID: 22174924
[TBL] [Abstract][Full Text] [Related]
9. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.
Gong K; Chen YF; Li P; Lucas JA; Hage FG; Yang Q; Nozell SE; Oparil S; Xing D
J Hypertens; 2011 Sep; 29(9):1810-9. PubMed ID: 21836474
[TBL] [Abstract][Full Text] [Related]
11. OP9 mouse stromal cells rapidly differentiate into adipocytes: characterization of a useful new model of adipogenesis.
Wolins NE; Quaynor BK; Skinner JR; Tzekov A; Park C; Choi K; Bickel PE
J Lipid Res; 2006 Feb; 47(2):450-60. PubMed ID: 16319419
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
Zhou B; Buckley ST; Patel V; Liu Y; Luo J; Krishnaveni MS; Ivan M; DeMaio L; Kim KJ; Ehrhardt C; Crandall ED; Borok Z
PLoS One; 2012; 7(6):e38827. PubMed ID: 22745681
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1.
Chang HJ; Lee JH; Hwang KJ; Kim MR; Chang KH; Park DW; Min CK
Fertil Steril; 2008 Oct; 90(4 Suppl):1357-65. PubMed ID: 18082740
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
[TBL] [Abstract][Full Text] [Related]
16. Axin expression in thymic stromal cells contributes to an age-related increase in thymic adiposity and is associated with reduced thymopoiesis independently of ghrelin signaling.
Yang H; Youm YH; Sun Y; Rim JS; Galbán CJ; Vandanmagsar B; Dixit VD
J Leukoc Biol; 2009 Jun; 85(6):928-38. PubMed ID: 19299626
[TBL] [Abstract][Full Text] [Related]
17. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
18. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
[TBL] [Abstract][Full Text] [Related]
19. Smad3-mSin3A-HDAC1 Complex is Required for TGF-β1-Induced Transcriptional Inhibition of PPARγ in Mouse Cardiac Fibroblasts.
Gong K; Chen M; Li R; He Y; Zhu H; Yao D; Oparil S; Zhang Z
Cell Physiol Biochem; 2016; 40(5):908-920. PubMed ID: 27941310
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta inhibits CCAAT/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells.
Ahdjoudj S; Kaabeche K; Holy X; Fromigué O; Modrowski D; Zérath E; Marie PJ
Exp Cell Res; 2005 Feb; 303(1):138-47. PubMed ID: 15572034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
